Replies to post #12212 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

I posted some Copaxone modeling assumptions in #msg-99111635. From those numbers, it’s fairly simple to get to a pseudo-GAAP EPS number (i.e. what MNTA’s GAAP EPS would be if MNTA were recording its Copaxone profit share as income).

I can connect up the dots if that’s necessary.